Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Biomedical Research Alliance of New York, New York

Memorial Sloan Kettering Cancer Center, New York

UPMC Cancer Pavillion, Pittsburgh

Mount Sinai Comprehensive Cancer Center, Miami Beach

Cleveland Clinic Foundation, Cleveland

The Linder Clinical Trial Center, Cincinnati

Spectrum Health, Grand Rapids

Carle Clinic, Urbana

Washington University School of Medicine, St Louis

Melanoma Center of St Louis, St Louis

Ellis Fischel Cancer Center, Columbia

University of Colorado, Aurora

University of Arizona Cancer Center, Tucson

University of Southern California Norris Cancer Center, Los Angeles

Outpatient Clinic, Santa Monica

St. Francis Memorial Hospital, San Francisco

UCLA, Los Angeles

The Harold Lever Regional Cancer Center, Waterbury

Lakeland Regional Cancer Center, Lakeland

Lutheran General, Park Ridge

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Ctr, Boston

Penn State Hershey Medical Center, Hershey

Sarah Cannon Cancer Center, Nashville

MD Anderson Cancer Center, Houston

Tom Baker Cancer Center, Calgary

Cross Cancer Institute, Edmonton

Cancer Care Manitoba, Winnipeg

Qell Health Sciences Center, Halifax

Princess Margaret Hospital, Toronto

L'Hotel Dieu de Quebec, Québec